Bengaluru/Mumbai, Feb. 10 -- India's HPV vaccine market is seeing a clear revival after years of low uptake, with digital health platforms and private healthcare providers reporting a sharp rise in demand amid growing awareness of cervical cancer prevention.

On PharmEasy, a digital-first diagnostics and pharmacy company backed by Prosus and Temasek, HPV vaccines now account for nearly 25% of total vaccine sales, making it one of the fastest-growing segments within its preventive healthcare portfolio. The rise reflects growing consumer awareness and easier access through digital channels, particularly in urban India.

"HPV vaccination has seen substantial growth on PharmEasy, driven by rising awareness about preventive healthcare and the ...